Swiss National Bank Lowers Stake in Revvity Inc. $RVTY

Swiss National Bank reduced its holdings in Revvity Inc. (NYSE:RVTY) by 2.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 224,300 shares of the company’s stock after selling 4,600 shares during the period. Swiss National Bank owned about 0.20% of Revvity worth $19,651,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Tudor Investment Corp ET AL acquired a new stake in Revvity during the 3rd quarter worth $15,128,000. Allspring Global Investments Holdings LLC increased its holdings in shares of Revvity by 127.0% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,751,612 shares of the company’s stock worth $171,921,000 after buying an additional 980,142 shares during the last quarter. SG Americas Securities LLC raised its position in Revvity by 186.8% in the fourth quarter. SG Americas Securities LLC now owns 123,173 shares of the company’s stock valued at $11,917,000 after purchasing an additional 80,226 shares during the period. KBC Group NV increased its position in shares of Revvity by 115.4% during the fourth quarter. KBC Group NV now owns 39,522 shares of the company’s stock valued at $3,824,000 after acquiring an additional 21,174 shares during the last quarter. Finally, Diamond Hill Capital Management Inc. lifted its holdings in shares of Revvity by 6.3% in the 4th quarter. Diamond Hill Capital Management Inc. now owns 426,899 shares of the company’s stock worth $41,302,000 after acquiring an additional 25,233 shares during the last quarter. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Revvity Price Performance

Shares of NYSE:RVTY opened at $110.56 on Friday. The company has a quick ratio of 1.41, a current ratio of 1.72 and a debt-to-equity ratio of 0.37. Revvity Inc. has a 52 week low of $81.22 and a 52 week high of $118.30. The company has a market cap of $12.33 billion, a P/E ratio of 52.90, a PEG ratio of 2.23 and a beta of 1.09. The company has a 50-day moving average price of $104.90 and a 200 day moving average price of $99.61.

Revvity (NYSE:RVTY) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.02 by $0.04. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The firm had revenue of $711.12 million for the quarter, compared to analyst estimates of $704.07 million. During the same quarter in the prior year, the company posted $1.01 earnings per share. Revvity’s quarterly revenue was up 7.0% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Research analysts predict that Revvity Inc. will post 5.25 earnings per share for the current year.

Revvity Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Friday, July 17th will be paid a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend is Friday, July 17th. Revvity’s dividend payout ratio (DPR) is presently 13.40%.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on RVTY. Zacks Research cut Revvity from a “hold” rating to a “strong sell” rating in a report on Monday, July 6th. Weiss Ratings upgraded shares of Revvity from a “sell (d)” rating to a “sell (d+)” rating in a research note on Wednesday, June 24th. TD Cowen reaffirmed a “buy” rating on shares of Revvity in a research report on Wednesday, July 15th. Wall Street Zen cut shares of Revvity from a “buy” rating to a “hold” rating in a report on Saturday, April 18th. Finally, The Goldman Sachs Group dropped their target price on shares of Revvity from $110.00 to $95.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 14th. Four research analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $108.92.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.